Literature DB >> 33643735

The Utility of the Neutrophil-Lymphocyte Ratio as an Early Diagnostic Marker in Neonatal Sepsis.

Santosh K Panda1, Manas K Nayak1, Soumini Rath2, Palash Das1.   

Abstract

Aim To find the diagnostic utility of the neutrophil to lymphocyte ratio (NLR) in the early diagnosis of neonatal sepsis. Methodology The case records of all blood culture-positive septic neonates admitted from January 2018 to December 2018 were reviewed. Total leucocyte count, absolute neutrophil count, absolute lymphocyte counts, NLR, and C-reactive protein (CRP) of septic neonates were compared with gestational age-matched nonseptic neonates by an unpaired t-test. The diagnostic performance of NLR and CRP was analyzed by receiver operating characteristic (ROC) analysis. Result A total of 41 blood culture-positive neonates and 52 nonseptic neonates were enrolled in this study. There was no significant difference in the total leucocyte count and absolute neutrophil counts of septic and nonseptic neonates. The mean absolute lymphocyte count of septic neonates (2795±1424/cumm) was significantly lower than that of nonseptic neonates (4449±1794/cumm; p=<0.001). The mean NLR of septic neonates (3.88±1.78) was significantly higher as compared to nonseptic (2.3404 ±1.98) neonates (p=0.045). For the diagnosis of sepsis, NLR at cutoff >1.7 had a sensitivity and specificity of 68.3% and 46.2%, respectively; CRP at cutoff >6 mg/dl had sensitivity and specificity of 78.05% and 92.31%, respectively. In the ROC analysis, the area under the curve (AUC) for CRP and NLR for the diagnosis of neonatal sepsis was 0.918 (p=<0.001) and 0.623 (p=0.042), respectively. Conclusion Blood culture-positive septic neonates had significantly higher NLR as compared to nonseptic neonates. However, when compared to CRP, NLR was not found to be a better predictor of sepsis in our study.
Copyright © 2021, Panda et al.

Entities:  

Keywords:  blood cell count; c-reactive protein; infants; neonates; neutrophil lymphocyte ratio

Year:  2021        PMID: 33643735      PMCID: PMC7902902          DOI: 10.7759/cureus.12891

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  24 in total

1.  Interpreting complete blood counts soon after birth in newborns at risk for sepsis.

Authors:  Thomas B Newman; Karen M Puopolo; Soora Wi; David Draper; Gabriel J Escobar
Journal:  Pediatrics       Date:  2010-10-25       Impact factor: 7.124

Review 2.  Getting to the site of inflammation: the leukocyte adhesion cascade updated.

Authors:  Klaus Ley; Carlo Laudanna; Myron I Cybulsky; Sussan Nourshargh
Journal:  Nat Rev Immunol       Date:  2007-09       Impact factor: 53.106

Review 3.  Biomarkers for diagnosis of neonatal sepsis: a literature review.

Authors:  Deepak Sharma; Nazanin Farahbakhsh; Sweta Shastri; Pradeep Sharma
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-07

4.  The Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio for Detecting Early-onset Neonatal Sepsis.

Authors:  Emrah Can; Şahin Hamilcikan; Ceren Can
Journal:  J Pediatr Hematol Oncol       Date:  2018-05       Impact factor: 1.289

5.  The neonatal blood count in health and disease. I. Reference values for neutrophilic cells.

Authors:  B L Manroe; A G Weinberg; C R Rosenfeld; R Browne
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

Review 6.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

7.  Can neutrophil to lymphocyte ratio predict late-onset sepsis in preterm infants?

Authors:  Senem Alkan Ozdemir; Esra Arun Ozer; Ozkan Ilhan; Sumer Sutcuoglu
Journal:  J Clin Lab Anal       Date:  2017-10-21       Impact factor: 2.352

8.  Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?

Authors:  Dragan Djordjevic; Goran Rondovic; Maja Surbatovic; Ivan Stanojevic; Ivo Udovicic; Tamara Andjelic; Snjezana Zeba; Snezana Milosavljevic; Nikola Stankovic; Dzihan Abazovic; Jasna Jevdjic; Danilo Vojvodic
Journal:  Mediators Inflamm       Date:  2018-07-15       Impact factor: 4.711

9.  Neutrophil-to-Lymphocyte Ratio as an Alternative Marker of Neonatal Sepsis in Developing Countries.

Authors:  Khadijah Rizky Sumitro; Martono Tri Utomo; Agung Dwi Wahyu Widodo
Journal:  Oman Med J       Date:  2021-01-06

10.  Diagnostic markers of acute infections in infants aged 1 week to 3 months: a retrospective cohort study.

Authors:  Uri Hamiel; Hilla Bahat; Eran Kozer; Yotam Hamiel; Tomer Ziv-Baran; Michael Goldman
Journal:  BMJ Open       Date:  2018-01-24       Impact factor: 2.692

View more
  4 in total

1.  Validation of Hematological Markers in Early Onset Neonatal Sepsis.

Authors:  Deepshikha Rana; Himadri Hazarika; Aditi Agarwal; Richa Gupta; Mrinalini Kotru
Journal:  Cureus       Date:  2022-06-30

2.  Comparison of Hematological and Biochemical Parameters of SARS-CoV-2-Positive and -Negative Neonates of COVID-19 Mothers in a COVID-19 Hospital, Odisha State.

Authors:  Santosh K Panda; Subhra Snigdha Panda; Deepti D Pradhan; Manas K Nayak; Arpan Ghosh; Nirmal K Mohakud
Journal:  Cureus       Date:  2022-04-05

3.  Salivary and Serum Interleukin-10, C-Reactive Protein, Mean Platelet Volume, and CRP/MPV Ratio in the Diagnosis of Late-Onset Neonatal Sepsis in Full-Term Neonates.

Authors:  Ahmed Omran; Hazem Sobh; Mohamed Osama Abdalla; Sonya El-Sharkawy; Ahmed R Rezk; Abdelmoneim Khashana
Journal:  J Immunol Res       Date:  2021-10-12       Impact factor: 4.818

4.  The Utility of Peripheral Blood Leucocyte Ratios as Biomarkers in Neonatal Sepsis: A Systematic Review and Meta-Analysis.

Authors:  Juanjuan Zhang; Jun'an Zeng; Liangjuan Zhang; Xiping Yu; Jinzhen Guo; Zhankui Li
Journal:  Front Pediatr       Date:  2022-07-22       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.